CHICAGO, July 26, 2024 /PRNewswire/ -- The
global Cell Isolation Market is expected to grow from
USD 4.6 billion in 2024 to
USD 8.4 billion by 2029, at a CAGR of
12.9%. The growth of the cell isolation market is driven by
advancements in technology and the development of new,
cost-effective, and user-friendly products. In recent years, key
players have introduced innovative products such as Thermo Fisher
Scientific's next-generation Gibco CTS Detachable Dynabeads, BD's
FACSDiscover S8 cell sorter, and ALFA LAVAL's CultureOne Maxi,
which are expected to boost adoption. Increased government funding
for cell-based research, such as the recent $2.9 million grant from the National Institute of
Neurological Disorders and Stroke to the University of Buffalo,
supports the development of new treatments for chronic diseases.
Additionally, the rising incidence of cancer and infectious
diseases, alongside a focus on personalized medicine and
next-generation therapeutics, is further propelling market growth.
However, the market faces challenges such as the high cost of
cell-based research and technical complexities in cell isolation
methods, which can limit the capabilities of smaller labs and
increase operational costs. The ecosystem comprises raw material
suppliers, manufacturers, and end-users, with consumables leading
the market in 2023. Adipose tissue was the dominant cell source due
to its applications in tissue engineering and regenerative
therapies. North America led the
market, followed by Europe and
Asia Pacific, due to its strong
healthcare infrastructure and R&D investments. Key players in
the market include Merck KGaA, Danaher Corporation, Thermo Fisher
Scientific, BD, and others.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479
Browse in-depth TOC on "Cell Isolation
Market"
456 - Tables
62 - Figures
475 -
Pages
DANAHER CORPORATION (US): Leader in Cell Separation and
Analysis
Danaher Corporation emerged as a leader in the cell separation
and analysis market due to its advanced technology, including
greater automation and precise instrumentation. The company excels
in improving cell separation reliability and efficiency, enabling
researchers to achieve accurate results and accelerate
breakthroughs in cellular biology. With a robust sales and
distribution network, Danaher's strong market presence is supported
by its Life Sciences and Biotechnology divisions, Beckman Coulter and Cytiva. The company focuses
on inorganic growth strategies like partnerships, acquisitions, and
expansions to enhance its market position. Notably, in March 2023, Danaher collaborated with the
University of Pennsylvania to develop
new technologies for improving clinical outcomes and addressing
production constraints in next-generation cell therapies.
MERCK KGaA (Germany):
Innovator in Cell Separation Kits and Reagents
In 2023, Merck KGaA distinguished itself with a broad range of
high-quality kits and reagents for cell separation from complex
sources. The company's commitment to innovation is evident in its
state-of-the-art tools and technical support that ensure precise
and efficient cell separation. Merck KGaA strengthens its market
position through strategic partnerships and significant investments
in research centers. For example, in April
2024, the company invested over USD
300 million in a new research center in Darmstadt, aimed at
advancing solutions for mRNA applications, antibody synthesis, and
biotechnological production, thereby enhancing its capabilities in
cell-based technologies.
THERMO FISHER SCIENTIFIC INC. (US): Pioneer in Cell Isolation
Solutions
Thermo Fisher Scientific Inc. maintains a leading position in
the cell isolation market with its diverse product portfolio and
extensive global presence. The company's focus on innovation is
exemplified by products such as the Gibco CTS Detachable Dynabeads.
Thermo Fisher supports research and
clinical needs with scalable solutions and adaptable platforms. The
company actively pursues partnerships and collaborations to advance
its market reach. In February 2024,
Thermo Fisher signed an agreement
with Multiply Labs to automate the cell therapy manufacturing
process, combining robotic technology with Thermo Fisher instruments to reduce costs,
shorten manufacturing times, and improve scalability.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479
Product Segmentation: Consumables Lead the Cell Isolation
Market
The global cell isolation market is segmented by product into
consumables and instruments. In 2023, consumables held the largest
share of the market. This dominance is primarily due to the high
demand for quality reagents that ensure reliable and reproducible
results, the single-use nature of consumables leading to repetitive
purchases, and advancements in cellular therapy and precision
medicine. Additionally, increased investments in developing
products such as magnetic beads and microfluidic chips, a growing
number of regulatory approvals for new consumables, and rising
government support for cell-based research contribute to the
substantial growth of the consumables segment.
Cell Type Segmentation: Human Cells Dominate
The global cell isolation market is classified by cell type into
animal cells and human cells, with human cells further subdivided
into differentiated cells and stem cells. In 2023, the human cells
segment led the market. This leadership is attributed to the
extensive use of isolated differentiated human cells in research,
academics, therapeutics, and biopharmaceutical & biotechnology
industries. Key applications include isolating pure cell
populations for biochemical analysis, using fluorescence-activated
cell sorting (FACS) for specific cell types, and isolating stem
cells from various sources for treatment processes.
Cell Source Segmentation: Adipose Tissue Holds the Largest
Share
Based on cell source, the market is divided into adipose tissue,
bone marrow, cord blood/embryonic stem cells, and other sources. In
2023, adipose tissue accounted for the largest share of the market.
This segment includes various adherent cell populations such as
adipose-derived stem/stromal cells (ASCs), adipose-derived adult
stem cells (ADAS), and processed lipoaspirate (PLA) cells. The
dominant share of adipose tissue is due to its increasing
application in tissue engineering.
Technique Segmentation: Centrifugation-Based Isolation
Leads
The cell isolation market is segmented by technique into
centrifugation-based, surface marker-based, and filtration-based
isolation. In 2023, centrifugation-based cell isolation held the
largest share. This technique is widely used by biotech and
biopharmaceutical companies, as well as clinical research
organizations and academic institutes, for developing and
manufacturing vaccines, enzymes, and antibodies. The segment's
growth is driven by a focus on advanced biotherapeutics
development.
Application Segmentation: Biomolecule Isolation
Dominates
The market is categorized by application into biomolecule
isolation, cancer research, stem cell research, tissue regeneration
and regenerative medicine, in-vitro diagnostics, and others. In
2023, biomolecule isolation was the leading application. The large
share is due to increasing demand for biopharmaceutical products,
advancements in cell analysis techniques, and the growth of the
global biopharmaceutical industry.
End-User Segmentation: Pharmaceutical & Biotechnology
Companies Lead
The cell isolation market is segmented by end user into
pharmaceutical & biotechnology companies, academic &
research institutes, hospitals & diagnostic laboratories, and
other users. In 2023, pharmaceutical and biotechnology companies
dominated the market. This segment's large share is driven by the
widespread adoption of advanced instruments for cell-based
experiments and cancer research, as well as the growing number of
R&D facilities globally.
Regional Insights: North America Holds the Largest
Share
The global cell isolation market is divided into regions:
North America, Europe, Asia
Pacific, Latin America,
Middle East, and Africa. In 2023, North America accounted for the largest share
of the market. This is due to the region's focus on advanced
cell-based therapies and healthcare infrastructure improvements.
However, the Asia Pacific region
is expected to be the fastest-growing market, driven by increasing
research practices in biotechnology and life sciences and
advancements in the biopharmaceutical industry.
For more information, inquire now! Inquire Now
Related Reports:
In Vitro Diagnostics Market
Single cell Analysis Market
Cell Culture Market
Infectious Disease Diagnostics Market
Cell Therapy Technologies Market
Get access to the latest updates on Cell Isolation
Companies and Cell Isolation Market Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us
on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan
Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo:
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/cell-isolationseparation-market-worth-8-4-billion-by-2029-driven-by-growing-emphasis-on-technological-advancements--marketsandmarkets-302207370.html